Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Aulos Bioscience, Inc.
Aulos Bioscience, Inc.
Hadassah Medical Organization
Fate Therapeutics
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)